S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Completed

• Conditions: Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms

• Registration Number: NCT00919425
• Lead Sponsor: SWOG Cancer Research Network

Brief Summary

RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how well patients will respond to treatment.

PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with hematologic cancer to be tested in the laboratory.

Detailed Description

Primary objective:

* Maintain and expand tissue repositories of highly characterized samples from patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, or myelodysplastic syndromes.

Other objectives as funding permits:

* Develop laboratory assays for rapid and precise diagnosis of leukemia using bone marrow and peripheral blood samples.

* Determine biologic, genetic, and molecular parameters that distinguish different subtypes of human leukemia with differing responses to therapy, and develop "risk-adapted" therapeutic approaches based on these parameters to tailor therapeutic regimens, randomize or stratify patients in clinical trials, or otherwise assist in therapeutic decision-making.

* Develop new automated and standardized laboratory methods for the detection and monitoring of therapeutic responsiveness and minimal residual disease in patients and use this information to design clinical trials.

OUTLINE: Patients receive treatment as directed by the Southwest Oncology Group (SWOG) study to which they are registered.

Patients undergo collection of peripheral blood (myeloid leukemia) or venous blood (lymphoid leukemia) and bone marrow at baseline, at the time of response or remission, and at the time of progression or relapse. Additional collections may take place according to the guidelines of the study in which the patient is registered.

Specimens are stored for use in laboratory research.

PROJECTED ACCRUAL: Samples from a maximum of 1,000 patients will be collected for this study.

Study Timeline

• Study Start: 1999-04
• Study First Submitted: 2009-06-11
• Study First Submitted QC: 2009-06-11
• Study First Posted: 2009-06-12
• Primary Completion: 2012-01
• Study Completion: 2012-01
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-05
• Last Update Posted: 2015-03-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1294

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maintenance and expansion of tissue repositories of highly characterized samples from patients with ALL, CLL, AML, CML, or myelodysplastic syndromes	While protocol was open

Trial Locations

Locations (292)

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center; 🇺🇸 Ft. Smith, Arkansas, United States

Alta Bates Summit Comprehensive Cancer Center; 🇺🇸 Berkeley, California, United States

Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center; 🇺🇸 Burbank, California, United States

Peninsula Medical Center; 🇺🇸 Burlingame, California, United States

North Bay Cancer Center; 🇺🇸 Fairfield, California, United States

Sutter Health - Western Division Cancer Research Group; 🇺🇸 Novato, California, United States

University of California Davis Cancer Center; 🇺🇸 Sacramento, California, United States

California Pacific Medical Center - California Campus; 🇺🇸 San Francisco, California, United States

Stanford Cancer Center; 🇺🇸 Stanford, California, United States

Sutter Solano Medical Center; 🇺🇸 Vallejo, California, United States

Scroll for more (282 remaining)